We Are Set to Distribute ResAppDX, an App that Diagnoses Lower Tract Respiratory Infections by Listening to Cough Sounds

ResAppDX is a point-of-care diagnostic phone application. It is compatible with both IOS and Android. It diagnoses lower respiratory tract infections by listening to cough sounds.

After an intensive pilot evaluation of the ResAppDx that we undertook at five partner clinics, we are elated to announce the signing of an agreement with ResApp Health, to distribute the diagnostic application in Kenya.

In the partnership with ResApp Health, we will, for an initial term of three years, sell and distribute the ResAppDX throughout our fast-growing market.

How ResAppDX works

ResAppDX is a point-of-care diagnostic phone application. It is compatible with both IOS and Android. It diagnoses lower respiratory tract infections by listening to cough sounds. This acute respiratory diagnostic test analyses the cough signatures it picks through a smartphone’s in-built microphone.

Patients cough and the application’s in-built technology detects lower tract infections. This provides accurate diagnostics which enable evidence-backed treatment.

Coughs and breathing sounds tell vital information about the condition of the respiratory tract. It is based on this that ResApp diagnoses and measures the severity of the following:

  • Pneumonia
  • Asthma
  • Bronchiolitis, and
  • Chronic obstructive pulmonary disease (COPD)

A game-changer

Doctors use stethoscopes to examine respiratory conditions, by listening to the activities of the lungs. While this has been of great help in making a diagnosis, ResApp comes in to improve accuracy and erase the need for human interpretation of respiratory sounds. Here is how:

Stethoscopes hear sounds that are compromised since the sound has to first pass through the chest musculature. This muffles high-pitched components of respiratory sounds. During a bout of coughs, however, the lungs are directly connected to the atmosphere. That is the opportunity that ResApp taps into through automated technology. The device picks audible respiratory sounds that carry crucial information about the respiratory tract condition.

Rolling out of ResAppDX

We are eager to commence the rolling out of ResApp, confident that it is a game-changer. Smartphones installed with ResApp will be provided to facilities that partner with us, and training given on how to effectively use the application.

We shall charge the facilities KES 220/test (VAT included), enabling them to detect respiratory tract infections in their patients and offer apt care and treatment, while increasing their revenue.

The ResApp runs on data bundles, and to facilitate this, we have come up with an arrangement where facilities buy prepaid test-bundles in set packages (similar to how we buy data bundles) on a need basis.

ResAppDx will be available in the market as soon as May 15th this year. We look forward to partnering with you to provide better and accessible health care for all.

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Share on linkedin
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *

Social Media

Most Popular

Get The Latest Updates

Subscribe to get email notifications whenever we publish new articles

No spam, notifications only about new products, updates.

Categories

On Key

Related Posts

EARLY DETECTION OF BREAST CANCER IN SUB-SAHARAN AFRICA

Unfortunately, most countries in Sub-Saharan Africa have not been able to implement and sustain screening programs due to financial, logistical, and sociocultural constraints. Though mammograms are the gold standard in breast cancer detection, the said constraints hinder their availability in most health facilities. That’s why at Ilara Health we want to provide you with as much information as possible on early detection of breast cancer and detection tools for low-resource settings.

SEPTEMBER IS OVARIAN CANCER AWARENESS MONTH

Ovarian cancer often goes undetected until it has spread to the pelvis and abdomen. At an advanced stage, ovarian cancer is more difficult to treat. Because it is difficult to detect in its early stages, there are more deaths from ovarian cancer than any other gynecological cancer.

WHY TESTING FOR COVID-19 IS STILL IMPORTANT

Experts cannot emphasize this enough: Now is not the time to slack off on measures to prevent the spread of COVID-19, including getting tested if you’ve been exposed to someone who’s sick or you’re feeling ill yourself. Your health is your wealth, especially in this pandemic.